UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes

Archives of Virology

Volumn 150, Issue 1, 2005, Pages 145-151

  Akgul B ^a,b   Lemme, W ^a   Garcia Escudero R ^b   Storey, A ^b   Pfister, H J ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CULTURE; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KERATINOCYTE; PAPILLOMA VIRUS; PROMOTER REGION; RADIATION EXPOSURE; ULTRAVIOLET RADIATION; VIROLOGY;

GENE EXPRESSION REGULATION, VIRAL; HUMANS; KERATINOCYTES; PAPILLOMAVIRIDAE; PROMOTER REGIONS (GENETICS); TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 5; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 12944332999     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-004-0398-4     Document Type: Article

References (22)

1. Akgul B, Karle P, Adam M, Fuchs PG, Pfister HJ (2003) Dual role of tumor suppressor p53 in regulation of DNA replication and oncogene E6-promoter activity of epidermodysplasia verruciformis-associated human papillomavirus type 8. Virology 308: 279-290
2. Berkhout RJ, Bouwes Bavinck JN, ter Schegget J (2000) Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 8: 2087-2096
3. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88: 10124-10128
4. De Villiers EM, Ruhland A, Sekaric P (1999) Human papillomaviruses in non-melanoma skin cancer. Sem Cancer Biol 9: 413-422
5. De Wet JR, Wood KV, DeLuca M, Helsinki DR, Subramani S (1987) Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 7: 725-737
6. Ensser A, Pfister H (1990) Epidermodysplasia verruciformis associated human papillomaviruses present a subgenus-specific organization of the regulatory genome region. Nucleic Acids Res 18: 3919-3922
7. Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, Breuer J, Proby CM (2000) Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 61: 289-297
8. Horn S, Pfister H, Fuchs PG (1993) Constitutive transcriptional activator of Epidermodysplasia verruciformis-associated human papillomavirus 8. Virology 196: 674-681
9. Jackson S, Harwood C, Thomas M, Banks L, Storey A (2000) Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 14: 3065-3073
10. Krubke J, Kraus J, Delius H, Chow L, Broker T, Iftner T, Pfister H (1987) Genetic relationship among human papillomaviruses associated with benign and malignant tumours of patients with epidermodysplasia verruciformis. J Gen Virol 68: 3091-3103
11. Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA, Metcalf RA, Stampfer MR, Fusenig N, Rogan EM, et al (1993) p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14: 833-839 (Erratum, 14: 1491)
12. Majewski S, Jablonska S (1995) Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 131: 1312-1318
13. May M, Grassmann K, Pfister H, Fuchs PG (1994) Transcriptional silencer of the human papillomavirus type 8 late promoter interacts alternatively with the viral trans activator E2 or with a cellular factor. J Virol 68: 3612-3619
14. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, et al (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708
15. Pajunk HS, May C, Pfister H, Fuchs PG (1997) Regulatory interactions of transcription factor YY1 with control sequences of the E6 promoter of human papillomavirus type 8. J Gen Virol 78: 3287-3195
16. Pfister H (2003) Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 31: 52-56
17. Purdie KJ, Pennington J, Proby CM, Khalaf S, de Villiers EM, Leigh IM, Storey A (1999) The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence. EMBO J 18: 5359-5369
18. Purdie KJ, Sexton CJ, Proby CM, Glover MT, Williams AT, Stables JN, Leigh IM (1993) Malignant transformation of cutaneous lesions in renal allograft patients: a role for human papillomavirus. Cancer Res 53: 5328-5333
19. Sesto A, Navarro M, Burslem F, Jorcano JL (2002) Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays. Proc Natl Acad Sci USA 99: 2965-2970
20. Shea C, Parrish J (1991) Non-ionising radiation and the skin. In: Goldsmith LA (ed) Physiology, biochemistry and molecular biology of the skin, 2nd ed. Oxford University Press, pp 910-927
21. Stubenrauch F, Malejczyk J, Fuchs PG, Pfister H (1992) Late promoter of human papillomavirus type 8 and its regulation. J Virol 66: 3485-3493
22. zur Hausen H (2000) Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92: 690-698